Gutsy Health develops the Gut Wealth line of liquid and capsule supplements that combine a clinically studied, shelf-stable postbiotic with targeted vitamins and minerals to promote bowel regularity and calmer digestion. Founded by Scottish entrepreneur Gemma Stuart after her 15-year struggle with IBS, the company positions its products as simple, evidence-backed alternatives to trend-driven remedies. The brand has already garnered industry recognition, winning a Scottish EDGE Award and the UK StartUp Award for MedTech & HealthTech of the Year, and is reportedly helping "thousands of people" manage uncomfortable gut symptoms. With its new capital, Gutsy Health plans to expand beyond its core direct-to-consumer channel into pharmacies, health stores and national retailers while accelerating e-commerce growth on platforms such as Amazon. The company will also invest in new product development, including a lighter, easier-to-store capsule formulation, and aims to enter international markets by 2026. Financially, the business is still in its early stages and has not disclosed revenue figures, but the recent funding underscores investor confidence in its science-based approach and growth trajectory.

Total raised

$0M

Funding rounds

1

Latest round

Equity

Latest activity

Dec 2025